Will Pfizer cut its sales force again, by nearly one third? Bloomberg reports that Pfizer may eliminate nearly one-third of its sales force. The plan, which is apparently under consideration by senior… more →
Impactiviti blogsilico wrote 3 weeks ago: The WSJ is reporting that Ray Elliot, the new CEO of Boston Scientific, told analysts on a conferenc … more →
solpropertygroup wrote 1 month ago: By Daniel Shea Tico Times Staff (Original here) Foreign direct investment may be down as a result of … more →
rleuty wrote 3 months ago: OrbusNeich Medical, a Hong Kong-based company with U.S. headquarters in Fort Lauderdale, has filed a … more →
Jeremy G wrote 5 months ago: Some good news on the gene therapy front in adenosine deaminase-deficient SCID patients and in rheum … more →
Jeffrey Clark wrote 5 months ago: Not all life sciences companies are struggling in this economy. While the layoffs across the Big P … more →
Steve Woodruff wrote 6 months ago: Will Pfizer cut its sales force again, by nearly one third? Bloomberg reports that Pfizer may elimin … more →
jwolpert wrote 8 months ago: While I would love to get feedback on my story at this year’s BIF, if you only have time for … more →
Steve Woodruff wrote 9 months ago: Is Eli Lilly the “mystery suitor” for ImClone? - Eli Lilly & Co. is in advanced talk … more →
Pete Steege wrote 1 year ago: Video production’s not just for Hollywood anymore I had the opportunity to tour Boston Scient … more →
Dani Dechter wrote 1 year ago: Boston Scientific will sell its stakes in startup companies, including those in Israeli startups suc … more →
John wrote 1 year ago: Philips Electronics announced on Friday that it will acquire Respironics for $66/share or about $5.1 … more →
benjohnson71 wrote 1 year ago: According to Medical Product Outsourcing, Boston Scientific settled a lawsuit with ECRI Institute. … more →
John wrote 1 year ago: Recently wrote a brief post on the GE-Boston Scientific partnership, but left a few questions unansw … more →
John wrote 1 year ago: Mid last week, GE and Boston Scientific made an interesting announcement wherein Boston Scientific … more →
Steve Woodruff wrote 1 year ago: The Good Stuff: BMS gets approval for new oncology drug (for breast cancer) Ixempra. Merck gets new … more →
Jose wrote 2 years ago: Think of millions of persons with more than 100 years. It is true. People are becoming older. Older … more →